1.Primary co-culture of cortical neurons and astrocytes of new-born SD rats.
Chengna WANG ; Li LIN ; Zhenfang DUAN ; Fei ZHONG ; Daiying ZUO ; Yingliang WU
Acta Pharmaceutica Sinica 2013;48(11):1729-32
This study is to establish a simple and practical co-culture method of cortical neurons and astrocytes of rats. The cortex of the new-born SD rats was digested by 0.125% pancreatic enzyme, and the differential adherence was applied to obtain the mixed cell suspension of neurons and astrocytes. A low concentration of cytarabine was used to inhibit the astrocytes in a moderate way to get neuronal and astrocyte co-culture. The morphological characteristics of the cells in different times were observed under the inverted microscope. The cells began to adhere the wall 2 h after the inoculation. Neurons and astrocytes grew in a good condition under the inverted microscope 9 days after the inoculation. The results of the immunofluorescence staining and Rosenfeld's staining indicated that the co-culture of neurons and astrocytes was successful and the ratio of neurons and astrocytes was close to 1:1. A new neurons and astrocytes co-culture method, which is simple and convenient, was successfully established. It will be an efficient method for the related researches about neuronal and astrocyte co-culture in vitro.
2.Effect of Huatan Sanjie Formula (化痰散结方) on Thyroid Angiogenesis and VEGFA/VEGFR2 Signaling Pathway in Graves' Disease Model Mice
Wenxin MA ; Xiaoyun ZHU ; Chengna WANG ; Jing XU ; Ximing LIU ; Yang TANG
Journal of Traditional Chinese Medicine 2024;65(19):2025-2031
ObjectiveTo investigate the possible mechanism of Huatan Sanjie Formula (化痰散结方, HSF) in treating Graves' disease (GD) from the perspective of thyroid angiogenesis. MethodsThirty-six BALB/c female mice were randomly divided into a normal control group (n=9) and a modeling group (n=27). Mice in the modeling group were injected with 2.0×109 PFU/ml of Ad-TSHR289 adenovirus into the tibialis anterior muscle to build GD model. Nine weeks after immunization, the successfully modeled mice were randomly divided into model group, methimazole (MMI) group and HSF group, with 9 mice in each group. The MMI group was given 5.2 mg/(kg·d) of methimazole tablets by gavage, while the HSF group was given HSF at a relative crude drug dosage of 7.02 g/(kg·d) by gavage. The normal control group and the model group were given 0.1 ml/10 g of pure water by gavage. All groups were administered intragastrically once a day for a total of 4 weeks. The levels of thyroxine (T4) and thyrotropin receptor autoantibodies (TRAb) in serum were detected by radioimmunoassay, while the pathological changes of the thyroid gland were assessed by HE staining. The vascular morphology of thyroid tissue was observed by CD34 immunohistochemical staining, and the microvessel density (MVD) was counted. The protein expression of vascular endothelial growth factor A (VEGFA) and vascular endothelial growth factor receptor 2 (VEGFR2) in thyroid was detected by Western-blot. ResultsCompared to those in the normal control group, the thyroid volume of the mice in the model group significantly increased with excessive congestion, and the pathology showed significant thyroid follicular hyperplasia, columnar and proliferated epithelial cells, and enlarged follicle size; serum T4 and TRAb significantly increased, as well as the count of thyroid MVD, and the protein expressions of thyroid VEGFA and VEGFR2 (P<0.01). Compared to those in the model group, the thyroid glands of the mice in the MMI group and the HSF group were significantly reduced, and the congestion was improved; pathology showed that thyroid follicular hyperplasia and epithelial cell proliferation were reduced, with smooth edges of the follicles and the significantly reduced inward protrusion; serum T4 and TRAb significantly decreased, as well as the thyroid MVD, thyroid VEGFA and VEGFR2 protein expressions (P<0.05 or P<0.01). There was no significant difference in all indicators between the MMI group and the HSF group (P>0.05). ConclusionHSF may inhibit thyroid angiogenesis by down-regulating thyroid VEGFA/VEGFR2 signaling pathway, thereby improving goitre and hyperfunction in GD mice.